Publications by authors named "Thomas Genevee"
Article Synopsis
- This study evaluated how certain biomarkers from pretreatment PET/CT scans relate to patient outcomes in those with metastatic breast cancer (mBC) receiving specific antibody-drug conjugates (ADCs) - Sacituzumab Govitecan (SG) and Trastuzumab Deruxtecan (T-DXd).
- Conducted on 128 patients, the research found that higher levels of total metabolic tumor volume (TMTV) and maximum tumor dissemination (Dmax) were linked to shorter overall survival (OS) and progression-free survival (PFS) in both treatment groups.
- The conclusion highlights the potential of these biomarkers for improving survival predictions and tailoring treatment plans for mTNBC and